These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 28744403)

  • 1. Genomic alterations in advanced gastric cancer endoscopic biopsy samples using targeted next-generation sequencing.
    Ge S; Li B; Li Y; Li Z; Liu Z; Chen Z; Wu J; Gao J; Shen L
    Am J Cancer Res; 2017; 7(7):1540-1553. PubMed ID: 28744403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sporadic Early-Onset Diffuse Gastric Cancers Have High Frequency of Somatic CDH1 Alterations, but Low Frequency of Somatic RHOA Mutations Compared With Late-Onset Cancers.
    Cho SY; Park JW; Liu Y; Park YS; Kim JH; Yang H; Um H; Ko WR; Lee BI; Kwon SY; Ryu SW; Kwon CH; Park DY; Lee JH; Lee SI; Song KS; Hur H; Han SU; Chang H; Kim SJ; Kim BS; Yook JH; Yoo MW; Kim BS; Lee IS; Kook MC; Thiessen N; He A; Stewart C; Dunford A; Kim J; Shih J; Saksena G; Cherniack AD; Schumacher S; Weiner AT; Rosenberg M; Getz G; Yang EG; Ryu MH; Bass AJ; Kim HK
    Gastroenterology; 2017 Aug; 153(2):536-549.e26. PubMed ID: 28522256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep Targeted Sequencing and Its Potential Implication for Cancer Therapy in Chinese Patients with Gastric Adenocarcinoma.
    Yu P; Wang Y; Yu Y; Wang A; Huang L; Zhang Y; Liu W; Wu H; Yao M; Du YA; Cheng X
    Oncologist; 2021 May; 26(5):e756-e768. PubMed ID: 33511732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
    Liang X; Vacher S; Boulai A; Bernard V; Baulande S; Bohec M; Bièche I; Lerebours F; Callens C
    Breast Cancer Res; 2018 Aug; 20(1):88. PubMed ID: 30086764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms.
    Mackenzie R; Kommoss S; Winterhoff BJ; Kipp BR; Garcia JJ; Voss J; Halling K; Karnezis A; Senz J; Yang W; Prigge ES; Reuschenbach M; Doeberitz MV; Gilks BC; Huntsman DG; Bakkum-Gamez J; McAlpine JN; Anglesio MS
    BMC Cancer; 2015 May; 15():415. PubMed ID: 25986173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing.
    Cai H; Jing C; Chang X; Ding D; Han T; Yang J; Lu Z; Hu X; Liu Z; Wang J; Shang L; Wu S; Meng P; Lin L; Zhao J; Nie M; Yin K
    J Transl Med; 2019 Jun; 17(1):189. PubMed ID: 31164161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective comprehensive genomic profiling of advanced gastric carcinoma cases reveals frequent clinically relevant genomic alterations and new routes for targeted therapies.
    Ali SM; Sanford EM; Klempner SJ; Rubinson DA; Wang K; Palma NA; Chmielecki J; Yelensky R; Palmer GA; Morosini D; Lipson D; Catenacci DV; Braiteh F; Erlich R; Stephens PJ; Ross JS; Ou SH; Miller VA
    Oncologist; 2015 May; 20(5):499-507. PubMed ID: 25882375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive analyses using next-generation sequencing and immunohistochemistry enable precise treatment in advanced gastric cancer.
    Kuboki Y; Yamashita S; Niwa T; Ushijima T; Nagatsuma A; Kuwata T; Yoshino T; Doi T; Ochiai A; Ohtsu A
    Ann Oncol; 2016 Jan; 27(1):127-33. PubMed ID: 26489445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of a novel panel of 24 genes with high frequencies of mutation in gastric cancer based on next-generation sequencing.
    Zeng HH; Yang Z; Qiu YB; Bashir S; Li Y; Xu M
    World J Clin Cases; 2022 May; 10(15):4761-4775. PubMed ID: 35801059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next generation sequencing of vitreoretinal lymphomas from small-volume intraocular liquid biopsies: new routes to targeted therapies.
    Cani AK; Hovelson DH; Demirci H; Johnson MW; Tomlins SA; Rao RC
    Oncotarget; 2017 Jan; 8(5):7989-7998. PubMed ID: 28002793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic profiling of somatic alterations by Oncomine Focus Assay in Korean patients with advanced gastric cancer.
    Park J; Lee SI; Shin S; Hong JH; Yoo HM; Kim JG
    Oncol Lett; 2020 Nov; 20(5):129. PubMed ID: 32934698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene mutations in gastric cancer: a review of recent next-generation sequencing studies.
    Lin Y; Wu Z; Guo W; Li J
    Tumour Biol; 2015 Sep; 36(10):7385-94. PubMed ID: 26364057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic Profiling of HER2-Positive Gastric Cancer: PI3K/Akt/mTOR Pathway as Predictor of Outcomes in HER2-Positive Advanced Gastric Cancer Treated with Trastuzumab.
    Díaz-Serrano A; Angulo B; Dominguez C; Pazo-Cid R; Salud A; Jiménez-Fonseca P; Leon A; Galan MC; Alsina M; Rivera F; Plaza JC; Paz-Ares L; Lopez-Rios F; Gómez-Martín C
    Oncologist; 2018 Sep; 23(9):1092-1102. PubMed ID: 29700210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and Genetic Characteristics of Early and Advanced Gastric Cancer.
    Ha GW; Hwang HP; Cho YG; Park J
    Curr Issues Mol Biol; 2024 Feb; 46(2):1208-1218. PubMed ID: 38392195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer gene profiling explores the possible precision medicine for diffuse-type gastric adenocarcinoma.
    Ishikawa M; Hayashi H; Sakamoto N; Tanaka S; Nishihara H
    Med Oncol; 2019 Nov; 37(1):10. PubMed ID: 31768798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TP53 mutation and MET amplification in circulating tumor DNA analysis predict disease progression in patients with advanced gastric cancer.
    Li J; Li Z; Ding Y; Xu Y; Zhu X; Cao N; Huang C; Qin M; Liu F; Zhao A
    PeerJ; 2021; 9():e11146. PubMed ID: 33959414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The landscape of actionable genomic alterations in lung adenocarcinomas in India.
    Sharma R; Kamireddy AP; Hussaini SM; Chatterjee S; Hasan Q; Jain J
    Front Genet; 2023; 14():1256756. PubMed ID: 38155717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Profiling of gene fusion involving targetable genes in Chinese gastric cancer.
    Liu ZH; Zhu BW; Shi M; Qu YR; He XJ; Yuan HL; Ma J; Li W; Zhao DD; Liu ZC; Wang BM; Wang CY; Tao HQ; Ma TH
    World J Gastrointest Oncol; 2022 Aug; 14(8):1528-1539. PubMed ID: 36160735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Landscape of somatic mutations in gastric cancer assessed using next-generation sequencing analysis.
    Pan X; Ji X; Zhang R; Zhou Z; Zhong Y; Peng W; Sun N; Xu X; Xia L; Li P; Lu J; Tu J
    Oncol Lett; 2018 Oct; 16(4):4863-4870. PubMed ID: 30250552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of cancer gene mutations using targeted sequencing in matched primary and recurrent gastric cancers after chemotherapy.
    Huh YJ; Cho SY; Cho MS; Lee KE; Lee JH
    Genes Genomics; 2022 Nov; 44(11):1425-1435. PubMed ID: 35622232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.